Bronchiolitis obliterans syndrome after allogeneic hematopoietic SCT: Phenotypes and prognosis

Bone Marrow Transplantation

Volumn 48, Issue 6, 2013, Pages 819-824

  Bergeron, A ^a   Godet, C ^b   Chevret, S ^c   Lorillon, G ^a   Peffault De Latour, R ^a   De Revel, T ^d   Robin, M ^a   Ribaud, P ^a   Socie G ^a   Tazi, A ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b POITIERS UNIVERSITY HOSPITAL   (France)

^c INSERM   (France)

^d PERCY MILITARY HOSPITAL   (France)

Author keywords

allogeneic hematopoietic SCT; bronchiolitis obliterans; prognostic factors; pulmonary function testing

Indexed keywords

ACETYLCYSTEINE; AZITHROMYCIN; BRONCHODILATING AGENT; BUDESONIDE PLUS FORMOTEROL; CORTICOSTEROID; ERYTHROMYCIN; FLUTICASONE PROPIONATE; MACROLIDE; MONTELUKAST; PREDNISONE;

ACUTE GRAFT VERSUS HOST DISEASE; ADOLESCENT; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; ASTHMA; BRONCHIOLITIS OBLITERANS; CHRONIC BRONCHITIS; CHRONIC GRAFT VERSUS HOST DISEASE; COMPUTER ASSISTED TOMOGRAPHY; DRUG EFFICACY; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; OBSTRUCTIVE AIRWAY DISEASE; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; STEROID THERAPY; SYSTEMIC THERAPY; TOTAL LUNG CAPACITY;

ADOLESCENT; ADULT; ALLOGRAFTS; BRONCHIOLITIS OBLITERANS; FEMALE; FOLLOW-UP STUDIES; HEMATOLOGIC DISEASES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; PHENOTYPE; RESPIRATORY FUNCTION TESTS; RETROSPECTIVE STUDIES; SYNDROME; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84879074298     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2012.241     Document Type: Article

References (20)

1. Bergeron A, Chevret S, Chagnon K, Petropoulou A, Robin M, Desseaux K et al. Prospective evaluation of the incidence, risk factors and clinical outcome of late onset non infectious pulmonary complications after allogeneic hematopoietic stem cell transplantation. Am J Respir Crit Care Med 2011; 183: Abstract 4667.
2. Afessa B, Peters SG. Chronic lung disease after hematopoietic stem cell transplantation. Clin Chest Med 2005; 26: 571-586.
3. Au BK, Au MA, Chien JW. Bronchiolitis obliterans syndrome epidemiology after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 2011; 17: 1072-1078.
4. Soubani AO, Uberti JP. Bronchiolitis obliterans following haematopoietic stem cell transplantation. Eur Respir J 2007; 29: 1007-1019.
5. Filipovich AH, Weisdorf D, Pavletic S, Socié G, Wingard JR, Lee SJ et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005; 11: 945-956.
6. Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R et al. Interpretative strategies for lung function tests. Eur Respir J 2005; 26: 948-968.
7. Williams KM, Chien JW, Gladwin MT, Pavletic SZ. Bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation. Jama 2009; 302: 306-314.
8. Chien JW, Duncan S, Williams KM, Pavletic SZ. Bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell transplantation-an increasingly recognized manifestation of chronic graft-versus-host disease. Biol Blood Marrow Transplant 2010; 16: S106-S114.
9. Standardized lung function testing. Official statement of the European Respiratory Society. Eur Respir J Suppl 1993; 16: 1-100.
10. Gail M, Simon R. Testing for qualitative interactions between treatment effects and patient subsets. Biometrics 1985; 41: 361-372.
11. Dudek AZ, Mahaseth H, DeFor TE, Weisdorf DJ. Bronchiolitis obliterans in chronic graft-versus-host disease: analysis of risk factors and treatment outcomes. Biol Blood Marrow Transplant 2003; 9: 657-666.
12. Chien JW, Martin PJ, Gooley TA, Flowers ME, Heckbert SR, Nichols WG et al. Airflow obstruction after myeloablative allogeneic hematopoietic stem cell transplantation. Am J Respir Crit Care Med 2003; 168: 208-214.
13. Philit F, Wiesendanger T, Archimbaud E, Mornex JF, Brune J, Cordier JF. Posttransplant obstructive lung disease ("bronchiolitis obliterans"): a clinical comparative study of bone marrow and lung transplant patients. Eur Respir J 1995; 8: 551-558.
14. Chan CK, Hyland RH, Hutcheon MA, Minden MD, Alexander MA, Kossakowska AE et al. Small-airways disease in recipients of allogeneic bone marrow transplants. An analysis of 11 cases and a review of the literature. Medicine 1987; 66: 327-340.
15. Bergeron A, Belle A, Chevret S, Ribaud P, Devergie A, Esperou H et al. Combined inhaled steroids and bronchodilatators in obstructive airway disease after allogeneic stem cell transplantation. Bone Marrow Transplant 2007; 39: 547-553.
16. Bashoura L, Gupta S, Jain A, Couriel DR, Komanduri KV, Eapen GA et al. Inhaled corticosteroids stabilize constrictive bronchiolitis after hematopoietic stem cell transplantation. Bone Marrow Transplant 2008; 41: 63-67.
17. Khalid M, Al Saghir A, Saleemi S, Al Dammas S, Zeitouni M, Al Mobeireek A et al. Azithromycin in bronchiolitis obliterans complicating bone marrow transplantation: a preliminary study. Eur Respir J 2005; 25: 490-493.
18. Or R, Gesundheit B, Resnick I, Bitan M, Avraham A, Avgil M et al. Sparing effect by montelukast treatment for chronic graft versus host disease: a pilot study. Transplantation 2007; 83: 577-581.
19. Norman BC, Jacobsohn DA, Williams KM, Au BK, Au MA, Lee SJ et al. Fluticasone, azithromycin and montelukast therapy in reducing corticosteroid exposure in bronchiolitis obliterans syndrome after allogeneic hematopoietic SCT: a case series of eight patients. Bone Marrow Transplant 2011; 46: 1369-1373.
20. Agosti JM, Sprenger JD, Lum LG, Witherspoon RP, Fisher LD, Storb R et al. Transfer of allergen-specific IgE-mediated hypersensitivity with allogeneic bone marrow transplantation. N Engl J Med 1988; 319: 1623-1628.